Biden administration reportedly eyeing booster expansion, following in several states' footsteps


The Biden administration is reportedly planning to begin expanding access to COVID-19 boosters to all adults as early as this week, though several states and cities have already beat them to it, reports Axios and The Wall Street Journal.
The decisions on both the federal and state level arrive ahead of the holidays, when families typically gather indoors and in large groups. Boosters have thus far been federally recommended only for the elderly and the high-risk.
With the White House dragging its feet, several states — like California, Colorado, Arkansas, and New Mexico — have already gone ahead and made boosters available to all adults at least six months out from their second dose, per the Journal. Officials in both New York City and West Virginia have also done the same, but have "stopped short of a formal policy change," notes The New York Times.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"We want you to get the booster because the data indicates that the effectiveness of the vaccine deteriorates over time," said Arkansas Gov. Asa Hutchinson (R).
"Boosters can provide one more layer of reassurance, allowing us to breathe a bit easier, either for ourselves or our loved ones," explained New York City Health Commissioner Dave Chokshi when announcing the Monday decision.
But despite the push, some experts don't believe broad boosting will prevent a winter surge. Said FDA vaccine-advisory panel member Paul Offit to the Journal: "If we really want to get on top of this pandemic, it's not a matter of boosting the vaccinated, it's a matter of vaccinating the unvaccinated."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the rise
The Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts